Crescent Biopharma (CBIO) Payables (2013 - 2025)
Crescent Biopharma (CBIO) reported Payables of $140000.0 for Q4 2025, down 98.06% year-over-year from $7.2 million in Q4 2024, and down 94.53% quarter-over-quarter from $2.6 million in Q3 2025.
Crescent Biopharma (CBIO) Payables (2013 - 2025) Analysis & Trends
Crescent Biopharma (CBIO) has 13 years of Payables data on file, last reported at $140000.0 in Q4 2025.
- Payables for Q4 2025 came in at $140000.0, down 98.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $140000.0 (down 98.06% YoY), and the FY2025 annual result was $140000.0, down 98.06% from the prior year.
- Payables declined to $140000.0 in Q4 2025 per CBIO's latest filing, from $2.6 million in the prior quarter.
- Over five years, Payables peaked at $7.2 million in Q4 2024 and troughed at $104671.0 in Q1 2025.
- A 5-year average of $1.6 million and a median of $960477.0 in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables soared 731.8% in 2024, then plunged 98.06% in 2025.
- A 5-year view of Payables shows it stood at $2.1 million in 2021, then plunged by 53.97% to $970191.0 in 2022, then slipped by 10.52% to $868115.0 in 2023, then soared by 731.8% to $7.2 million in 2024, then sank by 98.06% to $140000.0 in 2025.
- Business Quant data shows CBIO's Payables at $140000.0 in Q4 2025, $2.6 million in Q3 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 104,671.00 |
| Dec 31, 2024 | 7.22 Mn |
| Sep 30, 2024 | 581,794.00 |
| Jun 30, 2024 | 950,763.00 |
| Mar 31, 2024 | 755,534.00 |
| Dec 31, 2023 | 868,115.00 |
| Sep 30, 2023 | 329,885.00 |
| Jun 30, 2023 | 241,487.00 |
| Mar 31, 2023 | 480,151.00 |
| Dec 31, 2022 | 970,191.00 |
| Sep 30, 2022 | 852,125.00 |
| Jun 30, 2022 | 1.27 Mn |
| Mar 31, 2022 | 2.28 Mn |
| Dec 31, 2021 | 2.11 Mn |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | 1.17 Mn |
| Mar 31, 2021 | 2.14 Mn |